Search All News
Tannishtha Reya, PhD, is establishing the new Irving Cancer Drug Discovery Program, devoted to helping faculty accelerate research discoveries in their labs to the clinic.
Exciting new clinical investigations, including results of the ALPINE study, show promising, more effective treatment for patients with CLL.
Peter encourages others to look into clinical trials and not lose hope.
- February 9, 2022
Carmela Brunelli has remained in remission after completing a trial that offers a promising, entirely new bladder-saving treatment option for patients.
- October 29, 2021
Sharon Howell had an encouraging response as a patient in the I-SPY clinical trials, and the outcome could also translate to a lower likelihood of her cancer coming back in the future.
- September 9, 2021
The new $10 million Columbia-Pfizer Clinical Trials Diversity Initiative will aim to reduce health disparities by increasing the participation of underrepresented minorities in clinical trials.
- July 8, 2021
New clinical trial studies the application of focused ultrasound technique to deliver chemotherapy in patients with DIPG, an aggressive type of brain cancer.
- June 5, 2021
Results of a new phase 2 clinical trial demonstrate the potential of targeted therapy in combination with chemotherapy to treat patients with uterine leiomyosarcoma.
- May 20, 2021
A novel drug combination is showing early promise for an entirely new, bladder-saving treatment option for patients.
- November 13, 2020
November marks Pancreatic Cancer Awareness month, and in this in-depth Q+A, Dr. Gulam Manji takes us through the exciting advances in pancreatic cancer treatment and research.
- May 4, 2020
Dr. Matthew Dallos and colleagues have opened the first clinical trial testing an anti-IL-8 compound as a potential therapy against COVID-19.
- February 24, 2020
A new clinical trial for AL amyloidosis is paving the way for a promising new treatment option for patients with the rare organ-debilitating disease.